A phase 2b randomized, controlled trial of the efficacy of the GMZ2 malaria vaccine in African children (2016)
Attributed to:
Epidemiological and statistical research on health problems of developing countries: MRC Tropical Epidemiology Group
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.vaccine.2016.07.041
PubMed Identifier: 27477844
Publication URI: http://europepmc.org/abstract/MED/27477844
Type: Journal Article/Review
Parent Publication: Vaccine
Issue: 38
ISSN: 0264-410X